These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9114924)

  • 1. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
    Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
    Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of doxorubicin hydrochloride and vincristine sulfate in two portable infusion-pump reservoirs.
    Nyhammar EK; Johansson SG; Seiving BE
    Am J Health Syst Pharm; 1996 May; 53(10):1171-3. PubMed ID: 8734681
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of ondansetron hydrochloride and five antineoplastic medications.
    Stewart JT; Warren FW; King DT; Fox JL
    Am J Health Syst Pharm; 1996 Jun; 53(11):1297-300. PubMed ID: 8725205
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
    Svirskis D; Behera S; Naidoo N; Beachman J; Raina T; Zhou Y; Berkahn L; Costello I; Gu Y
    J Oncol Pharm Pract; 2019 Jun; 25(4):831-840. PubMed ID: 29540104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
    Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
    Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
    Dine T; Cazin JC; Gressier B; Luyckx M; Brunet C; Cazin M; Goudaliez F; Mallevais ML; Toraub I
    Pharm Weekbl Sci; 1992 Dec; 14(6):365-9. PubMed ID: 1475177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days.
    Hagan RL; Mallett MS; Fox JL
    Am J Health Syst Pharm; 1996 Jun; 53(12):1431-5. PubMed ID: 8781690
    [No Abstract]   [Full Text] [Related]  

  • 8. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
    Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
    Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ondansetron and dexamethasone infusion upon refrigeration.
    Rolin C; Hecq JD; Vanbeckbergen DF; Jamart J; Galanti LM
    Ann Pharmacother; 2011 Jan; 45(1):130-1. PubMed ID: 21156815
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
    Henry DW; Marshall JL; Nazzaro D; Fox JL; Leff RD
    Am J Health Syst Pharm; 1995 Nov; 52(22):2570-3. PubMed ID: 8590244
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability of ondansetron hydrochloride in syrups compounded from tablets.
    Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ
    Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride injection and in 5% dextrose injection.
    Evrard B; Ceccato A; Gaspard O; Delattre L; Delporte JP
    Am J Health Syst Pharm; 1997 May; 54(9):1065-8. PubMed ID: 9143656
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
    Chung KC; Chin A; Gill MA
    Am J Health Syst Pharm; 1995 Jul; 52(14):1541-3. PubMed ID: 7552896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
    Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
    Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of intravenous admixtures of doxorubicin and vincristine.
    Beijnen JH; Neef C; Meuwissen OJ; Rutten JJ; Rosing H; Underberg WJ
    Am J Hosp Pharm; 1986 Dec; 43(12):3022-7. PubMed ID: 3812509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron: design and development of oral pharmaceutical suspensions.
    Gallardo Lara V; Gallardo ML; Morales Hernandez ME; Ruiz Martinez MA
    Pharmazie; 2009 Feb; 64(2):90-3. PubMed ID: 19320280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
    Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
    J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags.
    Karlage K; Earhart Z; Green-Boesen K; Myrdal PB
    Am J Health Syst Pharm; 2011 Aug; 68(16):1537-40. PubMed ID: 21817086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet concentrate transfusion during polychemotherapy of children with solid tumors].
    Koposov PV; KovalevI VI; Strykov VA; Kovalev LV; Loseva MS; Starostina AIu; Prostomolotov OA; Zakharov MV
    Vopr Onkol; 2002; 48(3):365-8. PubMed ID: 12455364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.